A Prospective, Non-Randomized, Multi-Center Observational Study to Establish a Physical Baseline Profile for Individual Study Subjects Using Various Modalities and Identify Deviations Via Longitudinal Monitoring for Participants Ages 6 Through 18
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- New deviations: 12 months
研究概览
简要总结
The goal of this observational study is to learn about changes in health in children that develop over time that may impact overall health and a healthy lifespan. The main questions it aims to answer are:
- What are the changes in health that impact overall health and lifespan in children; and
- What test(s) are best at finding changes in health in children?
详细描述
The two parts of the PUER Research study include (1) Baseline health assessment and (2) blood tests including genetic, molecular, and laboratory profiling. The Baseline assessment will consist of a health history questionnaire interview. Genetic assessment will be conducted using peripheral blood samples. Molecular and laboratory assessments will be conducted using peripheral blood samples and, potentially, urine, stool, and/or saliva samples.
The study will result in cross-sectional and longitudinal real world data collection to inform if any tests used can inform of health changes for individuals and may predict long-term health outcomes. Researchers at study sites will not be blinded to the data being collected during this study.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 6 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •To participate in the study, patients must meet the following criteria:
- •Male or non-pregnant female; age 6 to less than
- •Females of childbearing potential (WOCBP) must have a negative urine pregnancy test (UPT) at all visits.
- •Presence of
- •At least one pathogenic genetic variant in a biological parent, which is annotated as pathogenic in at least one public database, such as dbSNP, ClinVar, VEP (variant effect predictor), etc.; OR
- •Presence of unexplained disease, illness, trait, or phenotype.
- •Approval is at the sole discretion of the sponsor.
排除标准
- •Patients who meet any of the following criteria will be excluded from study participation:
- •Unwillingness or inability to participate in the study.
- •Unwillingness or inability to provide assent as per inclusion criterion #1, including those who lack the capacity to provide assent and will obtain 18 years of age prior to completion of the study.
- •WOCBP a with positive pregnancy test at enrollment or at any visit.
结局指标
主要结局
New deviations: 12 months
时间窗: 12 months
The number of new deviations from a study subject's baseline profile 12 months after enrollment that were previously not known at time of enrollment.
New deviations: 6 months
时间窗: 6 months
The number of new deviations, not known at the time of enrollment, at 6 months after enrollment.
New deviations: 18 months
时间窗: 18 months
The number of new deviations, not known at the time of enrollment, at 18 months after enrollment.
New deviations: 24 months
时间窗: 24 months
The number of new deviations, not known at the time of enrollment, at 24 months after enrollment.
New deviations: 36 months
时间窗: 36 months
The number of new deviations, not known at the time of enrollment, at 36 months after enrollment.
次要结局
未报告次要终点